Iterative Sequencing and Variant Screening (ISVS) as a novel pathogenic mutations search strategy - application for TMPRSS3 mutations screen
Abstract Autosomal recessive diseases (ARD) are typically caused by a limited number of mutations whose identification is challenged by their low prevalence. Our purpose was to develop a novel approach allowing an efficient search for mutations causing ARD and evaluation of their pathogenicity witho...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-02315-w |
id |
doaj-8bd53056b97f4413bd8fabb621fa592d |
---|---|
record_format |
Article |
spelling |
doaj-8bd53056b97f4413bd8fabb621fa592d2020-12-08T00:59:46ZengNature Publishing GroupScientific Reports2045-23222017-05-017111010.1038/s41598-017-02315-wIterative Sequencing and Variant Screening (ISVS) as a novel pathogenic mutations search strategy - application for TMPRSS3 mutations screenUrszula Lechowicz0Tomasz Gambin1Agnieszka Pollak2Anna Podgorska3Piotr Stawinski4Andre Franke5Britt-Sabina Petersen6Malgorzata Firczuk7Monika Oldak8Henryk Skarzynski9Rafal Ploski10Department of Genetics, Institute of Physiology and Pathology of HearingInstitute of Computer Science, Warsaw University of TechnologyDepartment of Genetics, Institute of Physiology and Pathology of HearingDepartment of Genetics, Institute of Physiology and Pathology of HearingDepartment of Genetics, Institute of Physiology and Pathology of HearingInstitute of Clinical Molecular Biology, Kiel UniversityInstitute of Clinical Molecular Biology, Kiel UniversityDepartment of Immunology, Center of Biostructure Research, Medical University of WarsawDepartment of Genetics, Institute of Physiology and Pathology of HearingOto-Rhino-Laryngology Surgery Clinic, Institute of Physiology and Pathology of HearingDepartment of Medical Genetics, Center of Biostructure, Medical University of WarsawAbstract Autosomal recessive diseases (ARD) are typically caused by a limited number of mutations whose identification is challenged by their low prevalence. Our purpose was to develop a novel approach allowing an efficient search for mutations causing ARD and evaluation of their pathogenicity without a control group. We developed Iterative Sequencing and Variant Screening (ISVS) approach based on iterative cycles of gene sequencing and mutation screening, and ISVS Simulator software ( http://zsibio.ii.pw.edu.pl/shiny/isvs/ ) for assessment of detected variants’ significance. As shown by simulations, ISVS efficiently identifies and correctly classifies pathogenic mutations except for cases where the gene of interest has extremely high number of low frequency nonpathogenic variants. By applying ISVS, we found 4 known and 9 novel (p.C73Y, p.S124L, p.C194Mfs*17, c.782 + 2 T > A, c.953-5 A > G, p.L325Q, p.D334Mfs*24, p.R436G, p.M448T) TMPRSS3 variants among deaf patients. For 3 known and 5 novel variants the disease association was supported by ISVS Simulator odds >90:1. Pathogenicity of 6 novel mutations has been supported by in-silico predictions of variants’ deleteriousness. By directly comparing variant prevalence in patients and controls, disease association was demonstrated only for two variants and it was relatively weak (P < 0.05). Summarizing, ISVS strategy and ISVS Simulator are useful for detection of genetic variants causing AR diseases.https://doi.org/10.1038/s41598-017-02315-w |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Urszula Lechowicz Tomasz Gambin Agnieszka Pollak Anna Podgorska Piotr Stawinski Andre Franke Britt-Sabina Petersen Malgorzata Firczuk Monika Oldak Henryk Skarzynski Rafal Ploski |
spellingShingle |
Urszula Lechowicz Tomasz Gambin Agnieszka Pollak Anna Podgorska Piotr Stawinski Andre Franke Britt-Sabina Petersen Malgorzata Firczuk Monika Oldak Henryk Skarzynski Rafal Ploski Iterative Sequencing and Variant Screening (ISVS) as a novel pathogenic mutations search strategy - application for TMPRSS3 mutations screen Scientific Reports |
author_facet |
Urszula Lechowicz Tomasz Gambin Agnieszka Pollak Anna Podgorska Piotr Stawinski Andre Franke Britt-Sabina Petersen Malgorzata Firczuk Monika Oldak Henryk Skarzynski Rafal Ploski |
author_sort |
Urszula Lechowicz |
title |
Iterative Sequencing and Variant Screening (ISVS) as a novel pathogenic mutations search strategy - application for TMPRSS3 mutations screen |
title_short |
Iterative Sequencing and Variant Screening (ISVS) as a novel pathogenic mutations search strategy - application for TMPRSS3 mutations screen |
title_full |
Iterative Sequencing and Variant Screening (ISVS) as a novel pathogenic mutations search strategy - application for TMPRSS3 mutations screen |
title_fullStr |
Iterative Sequencing and Variant Screening (ISVS) as a novel pathogenic mutations search strategy - application for TMPRSS3 mutations screen |
title_full_unstemmed |
Iterative Sequencing and Variant Screening (ISVS) as a novel pathogenic mutations search strategy - application for TMPRSS3 mutations screen |
title_sort |
iterative sequencing and variant screening (isvs) as a novel pathogenic mutations search strategy - application for tmprss3 mutations screen |
publisher |
Nature Publishing Group |
series |
Scientific Reports |
issn |
2045-2322 |
publishDate |
2017-05-01 |
description |
Abstract Autosomal recessive diseases (ARD) are typically caused by a limited number of mutations whose identification is challenged by their low prevalence. Our purpose was to develop a novel approach allowing an efficient search for mutations causing ARD and evaluation of their pathogenicity without a control group. We developed Iterative Sequencing and Variant Screening (ISVS) approach based on iterative cycles of gene sequencing and mutation screening, and ISVS Simulator software ( http://zsibio.ii.pw.edu.pl/shiny/isvs/ ) for assessment of detected variants’ significance. As shown by simulations, ISVS efficiently identifies and correctly classifies pathogenic mutations except for cases where the gene of interest has extremely high number of low frequency nonpathogenic variants. By applying ISVS, we found 4 known and 9 novel (p.C73Y, p.S124L, p.C194Mfs*17, c.782 + 2 T > A, c.953-5 A > G, p.L325Q, p.D334Mfs*24, p.R436G, p.M448T) TMPRSS3 variants among deaf patients. For 3 known and 5 novel variants the disease association was supported by ISVS Simulator odds >90:1. Pathogenicity of 6 novel mutations has been supported by in-silico predictions of variants’ deleteriousness. By directly comparing variant prevalence in patients and controls, disease association was demonstrated only for two variants and it was relatively weak (P < 0.05). Summarizing, ISVS strategy and ISVS Simulator are useful for detection of genetic variants causing AR diseases. |
url |
https://doi.org/10.1038/s41598-017-02315-w |
work_keys_str_mv |
AT urszulalechowicz iterativesequencingandvariantscreeningisvsasanovelpathogenicmutationssearchstrategyapplicationfortmprss3mutationsscreen AT tomaszgambin iterativesequencingandvariantscreeningisvsasanovelpathogenicmutationssearchstrategyapplicationfortmprss3mutationsscreen AT agnieszkapollak iterativesequencingandvariantscreeningisvsasanovelpathogenicmutationssearchstrategyapplicationfortmprss3mutationsscreen AT annapodgorska iterativesequencingandvariantscreeningisvsasanovelpathogenicmutationssearchstrategyapplicationfortmprss3mutationsscreen AT piotrstawinski iterativesequencingandvariantscreeningisvsasanovelpathogenicmutationssearchstrategyapplicationfortmprss3mutationsscreen AT andrefranke iterativesequencingandvariantscreeningisvsasanovelpathogenicmutationssearchstrategyapplicationfortmprss3mutationsscreen AT brittsabinapetersen iterativesequencingandvariantscreeningisvsasanovelpathogenicmutationssearchstrategyapplicationfortmprss3mutationsscreen AT malgorzatafirczuk iterativesequencingandvariantscreeningisvsasanovelpathogenicmutationssearchstrategyapplicationfortmprss3mutationsscreen AT monikaoldak iterativesequencingandvariantscreeningisvsasanovelpathogenicmutationssearchstrategyapplicationfortmprss3mutationsscreen AT henrykskarzynski iterativesequencingandvariantscreeningisvsasanovelpathogenicmutationssearchstrategyapplicationfortmprss3mutationsscreen AT rafalploski iterativesequencingandvariantscreeningisvsasanovelpathogenicmutationssearchstrategyapplicationfortmprss3mutationsscreen |
_version_ |
1724395407419637760 |